In a significant move to overhaul the national healthcare landscape, Kuwait’s Minister of Health, Dr. Ahmed Abdulwahab Al-Awadhi, has officially approved a sweeping reduction in the costs of 1,922 essential medicines, dietary supplements, and pharmaceutical products. This ministerial decision is strategically designed to alleviate the financial burden on patients while positioning Kuwait as the most affordable destination for pharmaceuticals within the Gulf region. By aligning local pricing with international and regional benchmarks, the government aims to stabilize the market and ensure that residents have cost-effective access to life-saving treatments.

Beyond cutting costs, the Ministry of Health is actively modernizing its pharmaceutical sector by introducing 268 new medications to the local market. The updated inventory includes advanced therapies for chronic conditions such as cancer, diabetes, cardiovascular diseases, asthma, and obesity, alongside the latest antimicrobial drugs. This initiative underscores the ministry's broader commitment to enhancing healthcare accessibility and quality, ensuring that patients can obtain modern, high-standard treatments at prices that are among the most competitive in the Middle East.